(Q43624575)

English

Cost effectiveness of continuous terbinafine compared with intermittent itraconazole in the treatment of dermatophyte toenail onychomycosis: an analysis of based on results from the L.I.ON. study. Lamisil versus Itraconazole in Onychomycosis

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Cost effectiveness of continuous terbinafine compared with intermittent itraconazole in the treatment of dermatophyte toenail onychomycosis: an analysis of based on results from the L.I.ON. study. Lamisil versus Itraconazole in Onychomycosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

0 references

author name string

R Jansen

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

W K Redekop

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

F F Rutten

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PharmacoEconomics

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

401-410

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Pharmacoeconomic analysis of oral antifungal therapies used to treat dermatophyte onychomycosis of the toenails. A US analysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness analysis for onychomycosis therapy in Canada from a government perspective

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multinational pharmacoeconomic analysis of oral therapies for onychomycosis. The Onychomycosis Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Onychomycosis is more than a cosmetic problem

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Oral treatment of onychomycosis of the toe nails; comparison of cost-effectiveness of griseofulvin, itraconazole, ketoconazole and terbinafine]

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral antifungal agents for onychomycosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacoeconomic analysis of oral therapies for onychomycosis: a US model

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic evaluation of antifungal agents in the treatment of toenail onychomycosis in Germany

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New drugs for the nail fungus prevalent in elderly

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. The LION Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sample size calculation in economic evaluations

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind, randomized study comparing itraconazole pulse therapy with continuous dosing for the treatment of toe-nail onychomycosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of two new treatments for onychomycosis: an analysis of two comparative clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00019053-200119040-00007

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43624575&oldid=2206168051"